Oppenheimer Maintains Perform on Chemomab Therapeuticsto Perform

Moomoo 24/7 ·  Mar 8 08:45

Oppenheimer analyst Jeff Jones maintains Chemomab Therapeutics (NASDAQ:CMMB) from Perform to Perform.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment